UPDATE 1-AstraZeneca beats profit forecasts, helped by external deals
July 30, 2015 at 02:38 AM EDT
LONDON, July 30 (Reuters) - AstraZeneca revenue fell by a smaller-than-expected 7 percent in the second quarter, as income from spinning off assets offset generic competition to older medicines and a strong dollar.
